CenterWatch Publishes PRO Consulting Profile

In this industry profile, Dr. Jean Paty, Chief Scientist and Regulatory Advisor of PRO Consulting discusses the FDA's draft guidance on PROs in clinical research and the importance of measuring patient-reported endpoints from a regulatory perspective, including the process for developing an endpoint model to meet regulatory expectations.

RSS Feed